![]() |
Volumn 7, Issue 6, 2010, Pages 269-273
|
Analysis of GP73 in patients with HCC as a function of anti-cancer treatment
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALANINE AMINOTRANSFERASE;
ALPHA FETOPROTEIN;
ASPARTATE AMINOTRANSFERASE;
GOLGI PROTEIN 73;
PROTEIN;
UNCLASSIFIED DRUG;
ADULT;
AGED;
ALANINE AMINOTRANSFERASE BLOOD LEVEL;
ARTICLE;
ASPARTATE AMINOTRANSFERASE BLOOD LEVEL;
CANCER RECURRENCE;
CANCER THERAPY;
CHEMOEMBOLIZATION;
CLINICAL ARTICLE;
DISEASE FREE INTERVAL;
FEMALE;
HUMAN;
IMMUNOBLOTTING;
LIVER CELL CARCINOMA;
MALE;
PRIORITY JOURNAL;
RADIOFREQUENCY ABLATION;
RETROSPECTIVE STUDY;
AGED;
CARCINOMA, HEPATOCELLULAR;
FEMALE;
HUMANS;
IMMUNOBLOTTING;
LIVER NEOPLASMS;
MALE;
MEMBRANE PROTEINS;
MIDDLE AGED;
NEOPLASM RECURRENCE, LOCAL;
PROGNOSIS;
TREATMENT OUTCOME;
TUMOR MARKERS, BIOLOGICAL;
YOUNG ADULT;
|
EID: 79959709520
PISSN: 15740153
EISSN: 18758592
Source Type: Journal
DOI: 10.3233/CBM-2010-0190 Document Type: Article |
Times cited : (19)
|
References (7)
|